Inquire Before Buying - Asia-Pacific Digital Respiratory Device Market

Asia-Pacific Digital Respiratory Device Market Research Report: Forecast (2025-2030)

Asia-Pacific Digital Respiratory Device Market - By Device Type (Therapeutic Devices (CPAP Devices, BI-PAP Devices, Humidifiers, Nebulizers, Ventilators, Inhalers, Oxygen Concentra......tes, Resuscitators), Diagnostics Monitoring Devices (Spirometers, Pulse Oximeters), Consumables and Accessories, Respiratory Therapy Wearable Medical Device (Watch and Wristband), Disposables (Nasal Cannulas, Filters, Breathing Circuits)), By End-User (Homecare, Hospitals and Clinics, Ambulatory Care Centers), By Application (Chronic Obstructive Pulmonary Disease, Sleep Apnea, Asthma, Infectious Disease), By Country (China, India, Japan, Australia, New Zealand, South Korea, Rest of Asia-Pacific), By Company (Philips, 3M Healthcare, Astra Zenca Plc., Novartis AG, GE Healthcare, Masimo Corporation, Cipla Ltd., Resmed Ltd., Teva Pharmaceuticals Industries Ltd., Acorda Therapeutics),and others. Read more

Healthcare
Jun 2025
Pages 232
Report Format: PDF, Excel, PPT

Market Insights & Analysis: Asia-Pacific Digital Respiratory Device Market (2025-30):

The Asia-Pacific Digital Respiratory Device Market size was valued at around USD 9.59 billion in 2024 and is projected to reach USD 46.50 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 30.10% during the forecast period, i.e., 2025-30.

Most of the market expansion is attributed to the mounting instances of respiratory diseases, including asthma, chronic obstructive pulmonary disease, and sleep apnea, resulting in the frequent adoption of the digital technology-enabled medical device. Besides, the region’s widespread presence of other respiratory diseases, such as chronic bronchitis, emphysema, and wheezing, has swiftly augmented the demand for digital respiratory devices.

However, by means of new technological advancements in emerging economies coupled with bolstering public awareness and increased healthcare expenditure, several governments seek to mitigate respiratory ailments while improving medical facilities in their respective countries. Given the aftermath of Covid-19, China is pacing up with the inclusion of Artificial intelligence in the medicine and healthcare ecosystem. The goal is to optimize resource allocation, enhance service efficiency, and bring innovation in service and management modes.

Report Coverage	Details
Historical Years	2020–23
Base Years	2024
Forecast Years	2025–30
Market Value in 2024	USD 9.59 Billion
Market Value by 2030	USD 46.50 Billion
CAGR (2025–30)	30.10%
Top Key Players	Philips, 3M Healthcare, Astra Zenca Plc., Novartis AG, GE Healthcare, Masimo Corporation, Cipla Ltd., Resmed Ltd., Teva Pharmaceuticals Industries Ltd., Acorda Therapeutics, and others
Segmentation	By Device Type (Therapeutic Devices (CPAP Devices, BI-PAP Devices, Humidifiers, Nebulizers, Ventilators, Inhalers, Oxygen Concentrates, Resuscitators), Diagnostics Monitoring Devices (Spirometers, Pulse Oximeters), Consumables and Accessories, Respiratory Therapy Wearable Medical Device (Watch and Wristband), Disposables (Nasal Cannulas, Filters, Breathing Circuits)), By End-User (Homecare, Hospitals and Clinics, Ambulatory Care Centers), By Application (Chronic Obstructive Pulmonary Disease, Sleep Apnea, Asthma, Infectious Disease), By Country (China, India, Japan, Australia, New Zealand, South Korea, Rest of Asia-Pacific), By Company (Philips, 3M Healthcare, Astra Zenca Plc., Novartis AG, GE Healthcare, Masimo Corporation, Cipla Ltd., Resmed Ltd., Teva Pharmaceuticals Industries Ltd., Acorda Therapeutics),and others.
Key Report Highlights	Market Dimensions & Projections Pricing Evaluation Recent Strategic Moves by Companies Primary Stakeholders Import/Export Trend Analysis Competitive Landscape Assessment Emerging Opportunities Market Trends and Indicators

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Moreover, new regulatory opportunities and difficulties arise as machine learning and artificial intelligence (AI) become more frequent in digital health products and solutions. Thus, numerous regulatory agencies are actively developing regulatory frameworks that handle products utilizing AI/ML, such as Singapore’s HSA and Japan’s MHLW/PMDA. Furthermore, the rapid increase in the population of seniors and obese people will also likely present chances for the market for respiratory care devices to expand in the years to come. Nonetheless, the demand for respiratory care equipment may face additional challenges due to the numerous adverse effects on infants’ respiratory systems in the coming years.

Introduction

Product Definition
Research Process
Glossary
Market Segmentation

Executive Summary
Expert Verbatim- Interview Excerpts of Industry Experts
Asia-Pacific Digital Respiratory Device Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Units Sold
  2. By Revenues
2. Market Share & Analysis
  1. By Device Type
    1. Therapeutic Devices
      1. CPAP Devices
      2. BI-PAP Devices
      3. Humidifiers
      4. Nebulizers
      5. Ventilators
      6. Inhalers
      7. Oxygen Concentrates
      8. Resuscitators
    2. Diagnostics Monitoring Devices
      1. Spirometers
      2. Pulse Oximeters
    3. Consumables and Accessories
    4. Respiratory Therapy Wearable Medical Device
      1. Watch and Wristband
    5. Disposables
      1. Nasal Cannulas
      2. Filters
      3. Breathing Circuits
  2. By End-User
    1. Homecare
    2. Hospitals and Clinics
    3. Ambulatory Care Centers
  3. By Application
    1. Chronic Obstructive Pulmonary Disease
    2. Sleep Apnea
    3. Asthma
    4. Infectious Disease
  4. By Country
    1. China
    2. India
    3. Japan
    4. Australia
    5. New Zealand
    6. South Korea
    7. Rest of Asia-Pacific
  5. By Company
    1. Revenue Shares
    2. Strategic Factorial Indexing
    3. Competitor Placement in MarkNtel Quadrant
Asia Pacific Digital Respiratory Medical Device Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Units Sold
  2. By Revenue
2. Market Share & Analysis
  1. By Product Type
  2. By End-User
  3. By Application
3. China Digital Respiratory Medical Device Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Units Sold
    2. By Revenues
  2. Market Share & Analysis
    1. By Product
    2. By End-User
    3. By Application
4. India Digital Respiratory Medical Device Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Units Sold
    2. By Revenues
  2. Market Share & Analysis
    1. By Product
    2. By End-User
    3. By Application
5. Japan Digital Respiratory Medical Device Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Units Sold
    2. By Revenues
  2. Market Share & Analysis
    1. By Product
    2. By End-User
    3. By Application
6. Australia Digital Respiratory Medical Device Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Units Sold
    2. By Revenues
  2. Market Share & Analysis
    1. By Product
    2. By End-User
    3. By Application
7. New Zealand Digital Respiratory Medical Device Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Units Sold
    2. By Revenues
  2. Market Share & Analysis
    1. By Product
    2. By End-User
    3. By Application
8. South Korea Digital Respiratory Medical Device Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Units Sold
    2. By Revenue
  2. Market Share & Analysis
    1. By Product
    2. By End-User
    3. By Application
9. Rest of Asia-Pacific Digital Respiratory Medical Device Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. By Units Sold
    2. By Revenues
  2. Market Share & Analysis
    1. By Product
    2. By End-User
    3. By Application
Asia-Pacific Digital Respiratory Device Dynamics
1. Drivers
2. Challenges
3. Impact Analysis
Asia-Pacific Digital Respiratory Device Regulations, Product Standards
Asia-Pacific Digital Respiratory Device Value Chain Analysis
Asia-Pacific Digital Respiratory Device Intellectual Property Rights Analysis
Asia-Pacific Digital Respiratory Device Hotspots & Opportunities
Competition Outlook
1. Competitor Wise Growth Strategies
  1. Product Portfolio
  2. Brand Specialization
  3. Target Markets
  4. Research & Development
  5. Strategic Alliances & Initiatives
2. Company Profiles
  1. Philips
  2. 3M Healthcare
  3. Astra Zenca Plc.
  4. Novartis AG
  5. GE Healthcare
  6. Masimo Corporation
  7. Cipla Ltd.
  8. Resmed Ltd.
  9. Teva Pharmaceuticals Industries Ltd.
  10. Acorda Therapeutics
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO INQUIRE BEFORE BUYING THIS REPORT

Name *

Email ID *

Country *

Contact Number *

Your Enquiry Details

Your data is 100% confidential & secure

By submitting, you agree to our Terms and Privacy Policy .

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Related Reports

Talk to our Consultant

Customization Offered

Request Customization